bluebird bio, Inc. (0HOH.L)

USD 9.28

(33.91%)

Total Debt Summary of bluebird bio, Inc.

  • bluebird bio, Inc.'s latest annual total debt in 2023 was 330.32 Million USD , up 17.39% from previous year.
  • bluebird bio, Inc.'s latest quarterly total debt in 2024 Q1 was 414.34 Million USD , up 25.43% from previous quarter.
  • bluebird bio, Inc. reported annual total debt of 281.39 Million USD in 2022, up 214.11% from previous year.
  • bluebird bio, Inc. reported annual total debt of 89.58 Million USD in 2021, down -53.59% from previous year.
  • bluebird bio, Inc. reported quarterly total debt of 390.42 Million USD for 2024 Q2, down -5.77% from previous quarter.
  • bluebird bio, Inc. reported quarterly total debt of 330.32 Million USD for 2023 Q4, up 8.76% from previous quarter.

Annual Total Debt Chart of bluebird bio, Inc. (2023 - 2011)

Historical Annual Total Debt of bluebird bio, Inc. (2023 - 2011)

Year Total Debt Total Debt Growth
2023 330.32 Million USD 17.39%
2022 281.39 Million USD 214.11%
2021 89.58 Million USD -53.59%
2020 193.02 Million USD 1.06%
2019 190.98 Million USD 23.42%
2018 154.74 Million USD -0.68%
2017 155.8 Million USD 29.68%
2016 120.14 Million USD 94.08%
2015 61.9 Million USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Total Debt Comparison of bluebird bio, Inc.

Name Total Debt Total Debt Difference
Editas Medicine, Inc. 36.53 Million USD -804.111%
Dynavax Technologies Corporation 256.91 Million USD -28.575%
Supernus Pharmaceuticals, Inc. 41.52 Million USD -695.449%
Perrigo Company plc 4.07 Billion USD 91.891%
Illumina, Inc. 2.26 Billion USD 85.397%
Thermo Fisher Scientific Inc. 34.91 Billion USD 99.054%
Iovance Biotherapeutics, Inc. 1 Million USD -32932.6%
Walgreens Boots Alliance, Inc. 9.55 Billion USD 96.543%
IQVIA Holdings Inc. 14.23 Billion USD 97.679%
Heron Therapeutics, Inc. 173.75 Million USD -90.112%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 87.779%
Unity Biotechnology, Inc. 26.99 Million USD -1123.883%
Waters Corporation 2.35 Billion USD 85.976%
Biogen Inc. 7.33 Billion USD 95.499%
Sangamo Therapeutics, Inc. 38.1 Million USD -766.906%
Evolus, Inc. 126.54 Million USD -161.032%
Adicet Bio, Inc. 17.7 Million USD -1765.932%
Cara Therapeutics, Inc. 43.16 Million USD -665.228%
Esperion Therapeutics, Inc. 540.94 Million USD 38.936%
FibroGen, Inc. 170.45 Million USD -93.791%
Agilent Technologies, Inc. 2.73 Billion USD 87.922%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD -1481.7%
Homology Medicines, Inc. 44.05 Million USD -649.821%
Geron Corporation 85.89 Million USD -284.552%
Alnylam Pharmaceuticals, Inc. 2.39 Billion USD 86.225%
Amicus Therapeutics, Inc. 445.05 Million USD 25.779%
Myriad Genetics, Inc. 145 Million USD -127.811%
Viking Therapeutics, Inc. 1.26 Million USD -26116.349%
Intellia Therapeutics, Inc. 115.34 Million USD -186.378%
Zoetis Inc. 6.8 Billion USD 95.144%
Abeona Therapeutics Inc. 4.4 Million USD -7403.998%
Mettler-Toledo International Inc. 2.16 Billion USD 84.762%
BioMarin Pharmaceutical Inc. 1.13 Billion USD 70.868%
Vertex Pharmaceuticals Incorporated 808.4 Million USD 59.138%
Kala Pharmaceuticals, Inc. 36.32 Million USD -809.413%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD 77.274%
Atara Biotherapeutics, Inc. 57.87 Million USD -470.787%
Verastem, Inc. 41.55 Million USD -694.875%
Nektar Therapeutics 230.4 Million USD -43.37%
Axsome Therapeutics, Inc. 186.37 Million USD -77.24%
Aclaris Therapeutics, Inc. 3.07 Million USD -10645.804%
Sarepta Therapeutics, Inc. 1.39 Billion USD 76.351%
OPKO Health, Inc. 326.56 Million USD -1.152%
Exelixis, Inc. 189.94 Million USD -73.907%
Neurocrine Biosciences, Inc. 428.4 Million USD 22.893%
Corcept Therapeutics Incorporated 151 Thousand USD -218658.94%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 138.4 Million USD -138.659%
Imunon, Inc. 1.13 Million USD -28893.946%
Blueprint Medicines Corporation 774.12 Million USD 57.329%
Insmed Incorporated 1.2 Billion USD 72.564%
Halozyme Therapeutics, Inc. 1.49 Billion USD 77.967%
Agios Pharmaceuticals, Inc. 56.98 Million USD -479.641%
TG Therapeutics, Inc. 110.79 Million USD -198.142%
Incyte Corporation 38.28 Million USD -762.763%
Emergent BioSolutions Inc. 877.5 Million USD 62.356%